These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

705 related articles for article (PubMed ID: 14966406)

  • 1. A different amyloid formation mechanism: de novo oculoleptomeningeal amyloid deposits after liver transplantation.
    Ando Y; Terazaki H; Nakamura M; Ando E; Haraoka K; Yamashita T; Ueda M; Okabe H; Sasaki Y; Tanihara H; Uchino M; Inomata Y
    Transplantation; 2004 Feb; 77(3):345-9. PubMed ID: 14966406
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuroradiologic and clinicopathologic features of oculoleptomeningeal type amyloidosis.
    Nakamura M; Yamashita T; Ueda M; Obayashi K; Sato T; Ikeda T; Washimi Y; Hirai T; Kuwahara Y; Yamamoto MT; Uchino M; Ando Y
    Neurology; 2005 Oct; 65(7):1051-6. PubMed ID: 16217058
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Analyses of amyloid formation mechanism in familial amyloidotic polyneuropathy and therapeutic trial].
    Ando Y
    Rinsho Byori; 2000 May; 48(5):425-9. PubMed ID: 10892290
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Application to transthyretin analysis].
    Ueda M; Ando Y
    Rinsho Byori; 2006 Jun; 54(6):601-8. PubMed ID: 16872010
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transthyretin-derived amyloid deposition on the gastric mucosa in domino recipients of familial amyloid polyneuropathy liver.
    Takei Y; Gono T; Yazaki M; Ikeda S; Ikegami T; Hashikura Y; Miyagawa S; Hoshii Y
    Liver Transpl; 2007 Feb; 13(2):215-8. PubMed ID: 17029284
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical and pathological findings of non-Val30Met TTR type familial amyloid polyneuropathy in Japan.
    Ikeda S; Takei Y; Tokuda T; Nakazato M; Ando Y
    Amyloid; 2003 Aug; 10 Suppl 1():39-47. PubMed ID: 14640041
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of liver transplantation on familial amyloidotic polyneuropathy (FAP) patients' symptoms and complications.
    Suhr OB
    Amyloid; 2003 Aug; 10 Suppl 1():77-83. PubMed ID: 14640045
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oculoleptomeningeal amyloidosis in a patient with a TTR Val30Gly mutation in the transthyretin gene.
    Roe RH; Fisher Y; Eagle RC; Fine HF; Cunningham ET
    Ophthalmology; 2007 Nov; 114(11):e33-7. PubMed ID: 17980738
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Value of renal biopsy in the prognosis of liver transplantation in familial amyloid polyneuropathy ATTR Val30Met patients.
    Oguchi K; Takei Y; Ikeda S
    Amyloid; 2006 Jun; 13(2):99-107. PubMed ID: 16911964
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New therapeutic approaches for familial amyloidotic polyneuropathy (FAP).
    Ando Y
    Amyloid; 2003 Aug; 10 Suppl 1():55-66. PubMed ID: 14640043
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiac amyloid in patients with familial amyloid polyneuropathy consists of abundant wild-type transthyretin.
    Yazaki M; Tokuda T; Nakamura A; Higashikata T; Koyama J; Higuchi K; Harihara Y; Baba S; Kametani F; Ikeda S
    Biochem Biophys Res Commun; 2000 Aug; 274(3):702-6. PubMed ID: 10924339
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ocular manifestations in liver transplant recipients with familial amyloid polyneuropathy.
    Sandgren O; Kjellgren D; Suhr OB
    Acta Ophthalmol; 2008 Aug; 86(5):520-4. PubMed ID: 18435819
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Presence of autoantibody against ATTR Val30Met after sequential liver transplantation.
    Ando Y; Terazaki H; Haraoka K; Tajiri T; Nakamura M; Obayashi K; Misumi S; Shoji S; Hata K; Nakagawa K; Ishizaki T; Uemoto S; Inomata Y; Tanaka K; Okabe H
    Transplantation; 2002 Mar; 73(5):751-5. PubMed ID: 11907422
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transthyretin is not expressed by dorsal root ganglia cells.
    Sousa MM; Saraiva MJ
    Exp Neurol; 2008 Dec; 214(2):362-5. PubMed ID: 18835560
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epidemiology of familial amyloid polyneuropathy in Japan: Identification of a novel endemic focus.
    Kato-Motozaki Y; Ono K; Shima K; Morinaga A; Machiya T; Nozaki I; Shibata-Hamaguchi A; Furukawa Y; Yanase D; Ishida C; Sakajiri K; Yamada M
    J Neurol Sci; 2008 Jul; 270(1-2):133-40. PubMed ID: 18410945
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Secondary glaucoma in patients with familial amyloidotic polyneuropathy.
    Kimura A; Ando E; Fukushima M; Koga T; Hirata A; Arimura K; Ando Y; Negi A; Tanihara H
    Arch Ophthalmol; 2003 Mar; 121(3):351-6. PubMed ID: 12617705
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Diagnosis of familial amyloid polyneuropathy type I in Argentina].
    Pérez G; Romero MC; Trigo P; Lendoire J; Imventarza O; Nesse A
    Medicina (B Aires); 2008; 68(4):273-81. PubMed ID: 18786882
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ten years of international experience with liver transplantation for familial amyloidotic polyneuropathy: results from the Familial Amyloidotic Polyneuropathy World Transplant Registry.
    Herlenius G; Wilczek HE; Larsson M; Ericzon BG;
    Transplantation; 2004 Jan; 77(1):64-71. PubMed ID: 14724437
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk of transmission of systemic transthyretin amyloidosis after domino liver transplantation.
    Lladó L; Baliellas C; Casasnovas C; Ferrer I; Fabregat J; Ramos E; Castellote J; Torras J; Xiol X; Rafecas A
    Liver Transpl; 2010 Dec; 16(12):1386-92. PubMed ID: 21117248
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Familial amyloid polyneuropathy: a clinico-pathologic study.
    Said G; Planté-Bordeneuve V
    J Neurol Sci; 2009 Sep; 284(1-2):149-54. PubMed ID: 19467548
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 36.